Campbell & CO Investment Adviser LLC lessened its stake in shares of Xylem Inc. (NYSE:XYL – Free Report) by 72.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 14,902 shares of the industrial products company’s stock after selling 39,951 shares during the period. Campbell & CO Investment Adviser LLC’s holdings in Xylem were worth $2,198,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in XYL. Norges Bank acquired a new position in Xylem in the 2nd quarter valued at $338,232,000. ABN AMRO Bank N.V. acquired a new stake in Xylem in the 2nd quarter valued at about $208,226,000. Swedbank AB lifted its stake in Xylem by 19.0% in the 3rd quarter. Swedbank AB now owns 5,197,753 shares of the industrial products company’s stock worth $766,669,000 after purchasing an additional 830,821 shares in the last quarter. Amundi grew its position in shares of Xylem by 17.0% in the second quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock valued at $730,717,000 after purchasing an additional 830,337 shares in the last quarter. Finally, Voya Investment Management LLC increased its holdings in shares of Xylem by 544.0% in the third quarter. Voya Investment Management LLC now owns 868,755 shares of the industrial products company’s stock valued at $128,141,000 after purchasing an additional 733,860 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Insider Activity
In other Xylem news, Director Victoria D. Harker sold 1,700 shares of the business’s stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the sale, the director directly owned 16,875 shares in the company, valued at $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Claudia S. Toussaint sold 10,421 shares of the stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the sale, the executive vice president directly owned 31,250 shares in the company, valued at $4,770,000. This represents a 25.01% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.27% of the company’s stock.
Xylem Stock Up 1.1%
Xylem (NYSE:XYL – Get Free Report) last released its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The company had revenue of $2.27 billion for the quarter, compared to analysts’ expectations of $2.22 billion. During the same period in the prior year, the firm earned $1.11 earnings per share. The firm’s revenue was up 7.8% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Research analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.
Xylem Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date was Tuesday, November 25th. Xylem’s dividend payout ratio (DPR) is 41.13%.
Wall Street Analyst Weigh In
Several research analysts have recently commented on the company. Wall Street Zen lowered Xylem from a “buy” rating to a “hold” rating in a report on Saturday, December 27th. Weiss Ratings reissued a “buy (b-)” rating on shares of Xylem in a research note on Monday, December 29th. UBS Group lifted their price target on shares of Xylem from $168.00 to $175.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Argus set a $170.00 price objective on Xylem in a report on Wednesday, October 29th. Finally, Citigroup increased their price objective on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Xylem currently has an average rating of “Moderate Buy” and an average price target of $165.80.
Read Our Latest Stock Report on Xylem
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Recommended Stories
- Five stocks we like better than Xylem
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
